Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
11 DESCRIPTION DESCRIPTION SECTION MOUNJARO (tirzepatide) injection, for subcutaneous use, contains tirzepatide, a once weekly GIP receptor and GLP-1 receptor agonist
Compared to steroids, effects are more modest but with potentially fewer side effects and easier recovery
Are there specific precautions I should take if I have a history of certain medical conditions
Your monthly program includes: Once-weekly subcutaneous self-injection Triple receptor agonist targeting GLP-1, GIP, and glucagon Strongest weight loss data of any GLP compound to date Research compound offered under physician supervision No lab draw required
US$ 20.30
US$ 24.55
US$ 23.31
US$ 25.47
US$ 28.98
US$ 29.65
US$ 27.97
US$ 26.14
US$ 27.19
